Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors

This study reviews testosterone therapy for hypoactive sexual desire disorder (HSDD) in women, assessing its benefits and risks, especially following the introduction of PDE5 inhibitors. The article highlights that while testosterone may improve libido, its safety and long-term effects remain inconclusive. Several studies have explored this treatment, but no standardized